Combined Effects of Cisplatin and N, N-Diethyl-2-[4-(Phenylmethyl)Phenoxy] Ethanamine HCl on the Growth of Human Ovarian Cancer Xenografts in Nude Mice

By Hiramatsu H.   Kudoh K.   Kikuchi Y.   Hirata J.   Kita T.   Yamamoto K.   Tode T.   Nagata I.  

European Journal of Cancer, Vol. 33, Iss. 11, 1997-10 ,pp. : 1904-1905

Elsevier

Access to resources Recommend Favorite

The intracellular histamine antagonist, N,N-diethyl-2-[4-(phenylmethyl)phenoxy] ethanamine.HCl, may potentiate doxorubicin in the treatment of metastatic breast cancer: Results of a pilot study

By Brandes Lorne   Bracken Susan  

Breast Cancer Research and Treatment, Vol. 49, Iss. 1, 1998-05 ,pp. : 61-68

Springer Publishing Company

Access to resources Recommend Favorite

Induction of autophagy contributes to cisplatin resistance in human ovarian cancer cells

By  

Molecular Medicine Reports, Vol. 11, Iss. 1, 2015-01 ,pp. : 91-98

Spandidos Publications

Access to resources Recommend Favorite

Phase III study of N, N-Diethyl-2-[4-(Phenylmethyl) Phenoxyl] Ethanamine (BMS-2173801-01) combined with doxorubicin versus doxorubicin alone in metastatic/recurrent breast cancer: National Cancer Institute of Canada Clinical Trials Group Study MA-19

By  

The Women's Oncology Review, Vol. 4, Iss. 2, 2004-06 ,pp. : 133-134

Informa Healthcare

Access to resources Recommend Favorite

Iron metabolism disturbances in the MCF-7 human breast cancer cells with acquired resistance to doxorubicin and cisplatin

By                

International Journal of Oncology, Vol. 43, Iss. 5, 2013-01 ,pp. : 1481-1486

Spandidos Publications

Access to resources Recommend Favorite